Neuroscience Research (Mar 2024)

Analysis of splicing abnormalities in the white matter of myotonic dystrophy type 1 brain using RNA sequencing

  • Kazuki Yoshizumi,
  • Masamitsu Nishi,
  • Masataka Igeta,
  • Masayuki Nakamori,
  • Kimiko Inoue,
  • Tsuyoshi Matsumura,
  • Harutoshi Fujimura,
  • Kenji Jinnai,
  • Takashi Kimura

Journal volume & issue
Vol. 200
pp. 48 – 56

Abstract

Read online

Myotonic dystrophy type 1 (DM1) is a neuromuscular disorder caused by the genomic expansion of CTG repeats, in which RNA-binding proteins, such as muscleblind-like protein, are sequestered in the nucleus, and abnormal splicing is observed in various genes. Although abnormal splicing occurs in the brains of patients with DM1, its relation to central nervous system symptoms is unknown. Several imaging studies have indicated substantial white matter defects in patients with DM1. Here, we performed RNA sequencing and analysis of CTG repeat lengths in the frontal lobe of patients with DM1, separating the gray matter and white matter, to investigate splicing abnormalities in the DM1 brain, especially in the white matter. Several genes showed similar levels of splicing abnormalities in both gray and white matter, with an observable trend toward an increased number of repeats in the gray matter. These findings suggest that white matter defects in DM1 stem from aberrant RNA splicing in both gray and white matter. Notably, several of the genes displaying abnormal splicing are recognized as being dominantly expressed in astrocytes and oligodendrocytes, leading us to hypothesize that splicing defects in the white matter may be attributed to abnormal RNA splicing in glial cells.

Keywords